Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study
Clinical trial NCT06714370 · COMPLETED
Trial details
- NCT number
- NCT06714370
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-03
- Primary completion
- 2026-03-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.